The MSCV plasmid is owned and was provided by Dr. Robert Hawley of George Washington University. The IRES-GFP DNA was developed by Dr. Arthur Nienhuis of St. Jude Children's Research Hospital (SJCRH). Dr. John L. Cleveland cloned the human c-myc gene into the construct while at SJCRH. Dr. Cleveland obtained an MTA for this construct from SJCRH when he moved to the Scripps Research Institute, Florida.
The MSCV vector is described in; Hawley, R.G., Lieu, F.H.L., Fong, A.Z.C., and Hawley, T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1: 136-138, 1994. Use of the construct is described in; Park, I., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W., and Daley, G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141-146, 2008.
Please note that the assembled sequence presented here is not 100% reflective of the actual sequence. Addgene has found another HindIII site at the end of the MYC gene (see our quality control sequence).
Addgene has sequenced a portion of this plasmid for verification.
Click here for the sequencing
result.
Please acknowledge the principal investigator and cite this article if you use
this plasmid in a publication. Also, please include the text "Addgene plasmid
18119" in your Materials and Methods section.
The MSCV vector is described in; Hawley, R.G., Lieu, F.H.L., Fong, A.Z.C., and Hawley, T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1: 136-138, 1994.
Use of the construct is described in; Park, I., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W., and Daley, G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141-146, 2008.
Please note that the assembled sequence presented here is not 100% reflective of the actual sequence. Addgene has found another HindIII site at the end of the MYC gene (see our quality control sequence).